Health Canada drug identification number

DIN 02519844 — ALFUZOSIN 10 MG

ALFUZOSIN is a tablet (extended-release) of Alfuzosin marketed by SANIS HEALTH INC. The full Alfuzosin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02519844
Brand name
ALFUZOSIN
Active ingredient
Alfuzosin
Strength
10 MG
Dosage form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Manufacturer
SANIS HEALTH INC
Health Canada status
MARKETED
Drug class
Alpha1-adrenergic receptor antagonist (alpha-blocker)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Alfuzosin products

DINBrandStrengthFormManufacturerStatus
02447576 ALFUZOSIN 10 MG TABLET (EXTENDED-RELEASE) SIVEM PHARMACEUTICALS ULC MARKETED
02315866 APO-ALFUZOSIN 10 MG TABLET (EXTENDED-RELEASE) APOTEX INC MARKETED
02443201 AURO-ALFUZOSIN 10 MG TABLET (EXTENDED-RELEASE) AURO PHARMA INC MARKETED
02304678 SANDOZ ALFUZOSIN 10 MG TABLET (EXTENDED-RELEASE) SANDOZ CANADA INCORPORATED MARKETED
02245565 XATRAL 10 MG TABLET (EXTENDED-RELEASE) SANOFI-AVENTIS CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.